Company:Oviya MedSafe Pvt. Ltd
From HandWiki
Revision as of 04:53, 27 July 2022 by imported>WikiEditor (linkage)
Type | Knowledge Services Company |
---|---|
Industry | Pharmaceutical |
Founded | 2012 |
Founder | Dr J Vijay Venkatraman, Managing Director and Chief Executive Officer |
Headquarters | Coimbatore, India and London, United Kingdom |
Products | Pharmaceuticals |
Parent | Oviya MedSafe Pvt Ltd |
Subsidiaries | Oviya MedSafe UK Ltd |
Website | Oviya Medsafe Website |
Oviya MedSafe, a pharmacovigilance consulting and services company was founded in 2012, by Dr J Vijay Venkatraman, Managing Director and Chief Executive Officer. Oviya MedSafe provides comprehensive medical and drug safety service packages in line with the compliance requirements for pharmaceutical companies, contract research organizations, governmental and non-governmental health agencies, and marketing authorisation holders (MAHs) in India and the United Kingdom also expanding to the RoW (Rest of World) region. [1][2][3]
Oviya MedSafe supports the Central Drugs Standard Control Organization (CDSCO) regulations of India , this support encompasses the completion of Periodic Safety Update Reports (PSURs) on a timely basis.
Locations
- Oviya MedSafe Pvt Ltd
- Coimbatore, Tamil Nadu, India
- Oviya MedSafe UK Ltd
- London, United Kingdom
References
- ↑ "Oviya MedSafe Pvt Ltd: Private Company Information - Businessweek". Bloomberg.com. https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=228328212. Retrieved 2015-10-31.
- ↑ "Oviya MedSafe launches pharmacovigilance consulting and drug safety service packages – The Financial Express". Financialexpress.com. 2014-11-20. http://www.financialexpress.com/article/pharma/pharma-technology-review/oviya-medsafe-launches-pharmacovigilance-consulting-and-drug-safety-service-packages/11032/. Retrieved 2015-10-31.
- ↑ "Oviya MedSafe calls for streamlining Indian PSUR submission & review process". Pharmabiz.com. http://www.pharmabiz.com/NewsDetails.aspx?aid=87041&sid=1. Retrieved 2015-10-31.